$2.17
▼ -3.6% Today
as of Jul 22, 16:54 ET
Last 30 days
Recent Press Releases & News
Serina Says Panel Clears Dosing More Patients in Phase 1b Trial of SER-252 in Parkinson's Disease
Serina Therapeutics Announces Completion of Sentinel Dosing in Cohort 1 of Phase 1b Registrational Trial of SER-252 for Advanced Parkinson’s Disease
Gannet BioChem and Serina Therapeutics Enter Development Partnership Supporting SER-252 Program
Overview
52-week range
$1.22
$7.92
14% of range
Avg surprise (last 1)
-83.3%
Avg reaction (last 2)
+5.1%
50% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 14, 2026 | Mar/2026 | $-0.58 | — | — | -18.4% | +10.3% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.45 | — | — | — | — | financials |
| Mon Aug 11, 2025 | Jun/2025 | $-0.66 | $-0.36 | -83.3% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $-0.49 | — | — | — | -0.1% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.13 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.51 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-5.38 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.23 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.11 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Mon Aug 10, 2026 | Jun/2026 | OTHER | — | -$0.66 |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $0 | $130,000 | $0 | — | $14,000 | $51,000 |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | — | — | $-6M | $-6M | $-6M | — | $-5M | $-4M |
| Net income | $-7M | — | $-5M | $-6M | $-5M | — | $1M | $5M |
| EPS (diluted) | $-0.58 | — | $-0.45 | $-0.66 | $-0.49 | — | $0.13 | $0.51 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $25M | $3M | $9M | $6M | $4M | $4M | $3M | $6M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $26M | $6M | $11M | $8M | $6M | $6M | $5M | $9M |
| Total assets | $27M | $7M | $12M | $9M | $7M | $7M | $7M | $11M |
| Long-term debt | — | — | — | — | — | — | $11M | — |
| Total liabilities | $10M | $7M | $11M | $7M | $5M | $6M | $21M | $27M |
| Total equity | — | — | $2M | $2M | $2M | $641,000 | $-14M | $-16M |
Implied volatility — last 90 days
No IV snapshots yet for SER.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.